During the course of screening for novel gluconeogenesis inhibitors,. FR225659 and its related compounds were isolated from a fermentation broth of Helicomyces sp. No. 19353 . Spectroscopic analysis concluded that FR225659 is an N-acyl tripeptide consisting of a novel acyl, a 3-chloro-4-hydroxyarginine, a 3-hydroxy-3-methylproline and a dehydrovaline. Degradation study allowed assignment of the absolute configuration of the 3-hydroxy-3-methylproline to be (2S, 3R). FR225656 was shown to possess a dehydroisoleucine instead of the dehydrovaline of FR225659.
At present, over 150 millions people are suffering from diabetes in the world. While the cause of diabetes is still unclear, it is certain that high blood glucose level damages various human tissues, leading to complications such as neuropathy, retinopathy and kidney diseases. Thus, control of blood glucose level is prerequisite for diabetes patients. In assumption that gluconeogenesis inhibitors should be useful for down-regulation of blood glucose, we screened those inhibitors from microbial products and found FR225659, FR225656, and their three minor congeners in a cultured broth of Helicomyces sp. No. 193531,2) . Herein, structure determination of the two major metabolites, FR225659 (1) and FR225656 (2), will be discussed (Fig.  1 ).
Results and Discussion
Since FR225659 (1) exerted the most promising in vivo data among its congeners, our initial structure elucidation was focused on 1. In the ESI-MS spectrum, a protonated ion of 1 was observed at m/z 736 and 738 at a ratio of 3:1, indicating the existence of C1. Analysis of HRESI-MS and 1 3C NMR data concluded its molecular formula to be C36H42ClN7O8 (calcd. for C36H43ClN7O8 736.2862, found 736.2861). IR bands at 3390 (br), 1630 and 770cm-1 were indicative of carboxyl, amide and alkyl chloride functions, respectively. The 1H NMR spectrum in DMSO-d6 showed eight aromatic protons, two protons from an olefinic methylene, twelve protons from four singlet methyl, two amide protons, and a hydroxyl proton. The existence of a fused heterocyclic ring was indicated from a characteristic singlet proton observed at 8.86ppm. A pair of terminal olefinic protons resonating at 5.16 and 4.96ppm showed suggesting an isopropenyl group. The 13C NMR and HSQC spectra in DMSO-d6 showed four methyl, four methylene, twelve methine and sixteen quaternary carbons, explaining 36 carbons and 32 protons. The unexplained ten protons were supposed to be exchangeable ones. 2 ). These partial structures account for all the nineteen unsaturation degrees requested from the molecular formula of 1, which suggests 1 is a linear acylated tripeptide. Analysis of COSY data allowed junctions shown as bold lines in Fig. 2 . Further elucidation was carried out mainly using 1H-13C HMBC and 1H-15N HMBC in DMSO-d6. The acyl structure (a) including quinoline and phenol was deduced as follows. Two quaternary carbons, C-12 and C-17, were assigned to be orthogonal of a di-substituted benzene by strong HMBC cross peaks from 3JCH (14-H/C-12 and 15-H/C-17). A strong HMBC cross peak of 10-H/C-12 and 1H-15N HMBC correlations of 10-H/N-11 and 13-H/N-11 clarified that N-11 is adjacent to C-12 and C-10.
Bonds of C-9/C-10 and C-9/C-18 were deduced from HMBC correlations of 10-H/C-9, 10-H/C-18 and 20-H3/C-9. HMBC correlations of 10-H/C-8 and 16-H/C-8 allowed linkages of C-9/C-8/C-17, giving the quinoline structure.
The tri-substituted phenol was assigned with 1H NMR coupling patterns, characteristic 13C NMR chemical shifts HMBC correlation of 2'-H/C-1' allowed assignment of C-1', yielding 3-chloro-4-hydroxyarginine structure.
The proline analogue residue (c) was inferred as follows. HMBC correlations from 3"-CH3 to C-2", C-3" and C-4" allowed C-C bonds around the quaternary carbon at 3". Chemical shift of C-3" (75.7ppm) indicates that this carbon bears O-function. HMBC correlation from 2"-H to C-5" and C-2" as C-1" correlates with 2"-H in the HMBC spectrum.
The dehydrovaline (d) was deduced mainly using HMBC data. Strong HMBC cross peaks from singlet methyl at position 5"' to C-3"', C-2"' and C-4"' showed linkages of C-5"'/C-3"', C-3"'/C-2"' and C-3"'/C-4"'. A weak HMBC correlation of 5"'-H3/C-1"' suggested C-1"'/C-2"' bond.
Similar HMBC correlations were also observed from singlet methyl protons of position 4"' (not shown in Fig. 2 ). An amide proton resonating at 8.16ppm was correlated with C-3"' in the HMBC spectrum, which unveiled the dehydrovaline residue structure. The sequence of these substructures (a-b-c-d) was determined by sequential HMBC data and supported by NOE data (Fig. 3) . HMBC correlations of 2'-NH/C-1 and 2'-H/C-1 (weak) showed the C-1/2'-N bond to allow the acyl-3-chloro-4-hydroxyarginine sequence, which was supported by NOEs of 3-H/2'-NH and 7-H/2'-NH. Similarly, HMBC of 2"-H/C-1' and 2"'-NH/C-1", and 1H- of 3-chloro-4-hydroxyarginine-3-hydroxy-3-methylprolinedehydrovaline. This was supported by NOEs of 2'-H/5"-H (4.11ppm) and 2"-H/2"'-NH. Functionality of C-1"' was supposed to be carboxylic acid because C-1"' lacked met the molecular formula of 1 with assignments of 5-O and 3"-O to be free phenol and hydroxyl, respectively. With four protons from the guanidine and two protons from the amides, those assignments explain all of ten exchangeable protons of 1. Thereby, the planar structure of 1 is completed as shown in Fig. 3 .
The molecular formula of FR225656 (2) was determined to be C37H44ClN7O8 by HRESI-MS and HSQC data (calcd. for C37H45ClN7O8 750.3018, found 750.3033). Major spectral difference between 1 and 2 is that 2 exhibits ethyl signals in stead of methyl ones at 4"' in the 1H and 13C NMR spectra. As a consequence of similar NMR analysis with 1, 2 was proven to possess a dehydroisoleucine in place of the dehydrovaline in 1. The E-geometry of the dehydroisoleucine was shown by a NOE cross-peak of 2"'-NH/5"'-H3. 1H, 13C and 15N NMR assignments of 1 and 2 are depicted in Table 1 .
The remaining problem in this structure determination is stereochemistry of those compounds. All attempts to obtain suitable crystals for X-ray crystallography were in vain. It proved difficult to elucidate their stereochemistry using NMR, partly because they showed rather broad signals. Thus, we embarked on degradative study of 1. Acid hydrolysis (6N HCl) followed by methyl esterification and acylation with a chiral phthalic acid3) yielded 3 which gave fine crystals to allow X-ray crystallographic analysis. ORTEP drawing of 3 was shown in Fig. 4 . Thus, the stereochemistry of the 3-hydroxy-3-methylproline was determined to be (2S,3R). We are currently seeking milder conditions to transform 1 into simpler structures to determine the stereochemistry at position 2', 3' and 4'.
Conclusion
In conclusion, structure of 1 was determined to be 3-Hydroxy-3-methylproline was reported as a composite of polyoxypeptins6), and as a synthetic product in the course of total synthetic efforts on polyoxypeptins7). We believe the hydroxy group contributes to the high biological activity of 1 and 2 as well as their solubilities2 
